All Case Studies

Why Theranos Failed

Fraud

The blood-testing startup built on a lie

Theranos claimed to revolutionize blood testing with a device that could run hundreds of tests from a single finger prick. The technology never worked. Founder Elizabeth Holmes was convicted of fraud and sentenced to 11 years in prison.

97

Failure Predictability Score

Critical — This failure was highly predictable

$945M

Total Funding

$9B

Peak Valuation

~800 at peak

Employees

2003

Founded

2018

Failed

Palo Alto, USA

Headquarters

Risk Assessment Dashboard

Product Risk
Critical99

The core technology did not work. The Edison device could perform roughly 12 of the 200+ tests claimed. Most samples were secretly run on competitors' machines.

Founder Risk
Critical95

Elizabeth Holmes maintained absolute control, fired dissenters, and threatened whistleblowers with lawsuits. She created a culture of fear that silenced internal criticism.

Regulatory Risk
Critical92

Medical diagnostics require FDA clearance and CLIA compliance. Theranos operated in a gray area until CMS audits revealed systematic noncompliance.

Governance Risk
Critical88

Board stacked with political figures (Kissinger, Shultz, Mattis) who provided prestige but had zero medical device or diagnostics expertise.

Patient Safety Risk
Critical96

Inaccurate test results affected real medical decisions. Some patients received false positives for HIV and cancer. Patient harm was not hypothetical — it was documented.

Founders

Elizabeth Holmes

Executive Summary

Elizabeth Holmes dropped out of Stanford at 19 to build a device that could run 200+ blood tests from a tiny finger-prick sample. For over a decade, she raised $945 million from investors including Rupert Murdoch, the Walton family, and the DeVos family, reaching a $9 billion valuation. The problem: the technology never worked. Theranos secretly ran most tests on standard machines from Siemens and other manufacturers while telling the world their proprietary 'Edison' device was revolutionary. A 2015 Wall Street Journal investigation by John Carreyrou exposed the fraud, leading to criminal charges. Holmes was convicted in 2022 and sentenced to over 11 years in prison.

Timeline — 15 Years

2003

Elizabeth Holmes dropped out of Stanford at 19 to found Real-Time Cures, later renamed Theranos

2010

Signed first military contract. Total funding reached $45M

2013

Partnered with Walgreens to put Theranos testing centers in stores. Raised $95M from investors

2014

Valuation reached $9B. Elizabeth Holmes named youngest self-made female billionaire by Forbes. Board included Henry Kissinger, George Shultz, and Jim Mattis

2015

October: Wall Street Journal's John Carreyrou published investigation exposing that the Edison device could only run a small fraction of claimed tests

2016

CMS revoked Theranos lab licenses. Walgreens terminated partnership. Voided two years of test results affecting tens of thousands of patients

2018

SEC charged Holmes with 'massive fraud.' Company dissolved and assets sold to cover debts

2022

Elizabeth Holmes found guilty on four counts of fraud against investors

2023

Sentenced to 11 years and 3 months in federal prison. Began serving sentence in May

What Went Wrong

5 root causes
1

The core product did not work. The Edison device could reliably perform only about 12 of the 200+ tests Theranos claimed. For most tests, samples were secretly diluted and run on standard commercial machines.

2

Theranos operated under extreme secrecy, even internally. Engineers were siloed so no single team could see the full picture. Employees who raised concerns were threatened with lawsuits.

3

The board was stacked with political heavyweights — former Secretaries of State, retired generals, US Senators — but had zero healthcare or diagnostics expertise. They provided credibility without scrutiny.

4

Patient safety was compromised. Inaccurate test results affected real medical decisions. Some patients received false positives for serious conditions including HIV and cancer.

5

Investors relied on the founder's charisma and the board's prestige rather than independent verification. No major investor demanded to see the technology actually work before writing checks.

Lessons for Founders

5 takeaways

If your technology does not work, no amount of storytelling will save you. Faking it until you make it has a very different ending when human health is involved.

Prestigious advisors are not a substitute for domain experts. A board that cannot evaluate your core product is not a board — it is a marketing brochure.

Secrecy is not the same as competitive advantage. When employees cannot talk to each other, you are not protecting IP — you are hiding problems.

Healthcare products cannot skip clinical validation. The standards exist because lives depend on accuracy. There are no shortcuts.

Due diligence means seeing the product work. Investor trust should be earned through demonstrated results, not through carefully stage-managed demos.

How Proper Validation Could Have Prevented This

Theranos is the textbook case for why product validation cannot be skipped. A single independent technical audit at any point in the company's 15-year history would have revealed that the Edison device did not work as claimed. For founders in deeptech and healthcare: third-party validation is not optional. If your product makes claims about performance, those claims must be independently verifiable. For investors: never accept a demo environment as proof. Insist on seeing the product work in real conditions with real data. Theranos showed carefully rehearsed demos while the actual devices sat broken in the lab.

The Verdict — Could It Have Been Saved?

No. The fundamental premise was fraudulent. The technology did not work, and rather than pivoting to what was achievable — perhaps a more limited but honest diagnostic panel — Holmes chose to double down on deception. The moment patient safety was compromised, there was no ethical path forward.

Frequently Asked Questions

Q.Did Theranos technology ever work?

No. The Edison device could reliably run approximately 12 of the 200+ tests Theranos claimed. For the vast majority of tests, patient samples were secretly diluted and run on standard commercial machines manufactured by Siemens and other established companies.

Q.How much money did Theranos raise?

Theranos raised approximately $945 million from private investors including Rupert Murdoch ($125M), the Walton family ($150M), the DeVos family ($100M), and numerous other high-net-worth individuals. None of these investors received any return on their investment.

Q.Where is Elizabeth Holmes now?

Elizabeth Holmes is currently serving an 11-year and 3-month sentence at a federal prison camp in Bryan, Texas. She began serving her sentence in May 2023 after being convicted on four counts of fraud in January 2022.

Q.Were patients harmed by Theranos?

Yes. Inaccurate test results led to real medical consequences. Some patients received false positives for HIV and cancer, causing unnecessary emotional distress and follow-up procedures. In 2016, Theranos was forced to void two years of test results, affecting tens of thousands of patients.

Competitors That Survived

Quest DiagnosticsLabCorpAbbott

Sources & References

Root Cause

Core technology never worked as claimed. Systematic deception of investors, patients, and partners

Building a startup? Validate before you build.

PlanMySaaS uses AI to research your market, analyze competitors, and build a complete product plan — so you avoid the patterns that killed Theranos.

Start Free